| CYTH Shares Outstanding History Table | ||||||||||||||||||||||||||||||||||||||
Below is a table of the CYTH shares outstanding history going back to 12/9/2020:
Also see: CYTH Market Cap History CYTH YTD Return |
As of 11/12/2024 Cyclo Therapeutics has 28.77 million CYTH shares outstanding. Investors often track the CYTH shares outstanding history to compare shareholder return trends against the change in share count over time.
This page shows CYTH share count trends over time, with 18 historical shares outstanding datapoints presented, dating back to 12/9/2020.

| CYTH Shares Outstanding History Table | ||||||||||||||||||||||||||||||||||||||
Below is a table of the CYTH shares outstanding history going back to 12/9/2020:
Also see: CYTH Market Cap History CYTH YTD Return |
| CYTH Shares Outstanding History Chart | |||||||||||||||||||||||||||||||||||||||
CYTH Historical Shares Outstanding: +65.23% CAGR
Mouse over chart for data details
| |||||||||||||||||||||||||||||||||||||||
| CYTH Stock Price Chart |
| About Cyclo Therapeutics Inc |
| Cyclo Therapeutics, Inc. is a clinical-stage biotechnology company. Co. is focused on developing transformative therapies for rare and neurological diseases with limited treatment options. Co.'s Trappsol Cyclo is a proprietary formulation of hydroxypropyl beta cyclodextrin. It is an orphan drug designated product in the U.S. and Europe, and is the subject of four formal clinical trials for Niemann-Pick Disease Type C (NPC) disease. NPC is a rare and fatal autosomal recessive genetic disease resulting in disrupted cholesterol metabolism that impacts the brain, lungs, liver, spleen, and other organs. We show 18 historical shares outstanding datapoints in our coverage of CYTH's shares outstanding history. Understanding the changing numbers of CYTH shares outstanding — and comprehending the concept of differing number of shares outstanding in general comparing companies like CYTH versus peers — is critical for investors. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies. Furthermore, via issuance of new shares over time, or the repurchase of existing shares, the number of shares outstanding can fluctuate over the course of history. With this page we aim to empower investors researching CYTH by allowing them to research CYTH shares outstanding history as well as any other stock in our coverage universe. |
| CYTH Current Stock Quote |
Quotes delayed 20 minutes Get Dividend Alerts Get SEC Filing Alerts |
| Video: Shares Outstanding Importance | |
|
| CYTH Share Performance |
| Shares Outstanding Peers |
| Cyclo Therapeutics (CYTH) is categorized under the Healthcare sector; to help you further research historical shares outstanding numbers, below are some other companies in the same sector:
CYTK Shares Outstanding History CYTR Shares Outstanding History CYTX Shares Outstanding History DARE Shares Outstanding History DAWN Shares Outstanding History DBTX Shares Outstanding History DCGO Shares Outstanding History DCOY Shares Outstanding History DCPH Shares Outstanding History DCTH Shares Outstanding History More Healthcare companies » |
Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 8.2%—Every Month—Forever.
You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 8.2%.